Solifenacin for overactive bladder in women unsuccessfully treated with immediate release oxybutynin: A pilot study

Journal of Obstetrics and Gynaecology

Volumn 29, Issue 1, 2009, Pages 31-34

  Wong, C ^a,b   Duggan, P ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Solifenacin in the treatment of overactive bladder

Indexed keywords

ESOMEPRAZOLE; OXYBUTYNIN; SOLIFENACIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; MIXED INCONTINENCE; NOCTURIA; OPEN STUDY; OVERACTIVE BLADDER; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URGE INCONTINENCE; URINARY FREQUENCY; URINE VOLUME;

ADULT; AGED; CHOLINERGIC ANTAGONISTS; FEMALE; HUMANS; MANDELIC ACIDS; MIDDLE AGED; NOCTURIA; PILOT PROJECTS; QUALITY OF LIFE; QUINUCLIDINES; TETRAHYDROISOQUINOLINES; TREATMENT FAILURE; URINARY BLADDER, OVERACTIVE;

EID: 65249087335     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610802628726     Document Type: Article

References (14)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. Standardisation Sub-committee of the International Continence Society. 2002. The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neu-rourology and Urodynamics 21:167-178.
2. Brown JS, McGhan WF, Chokroverty S. 2000. Comorbidities associated with overactive bladder. American Journal of Managed Care 6:S574-S579.
3. Cardozo L, Coyne KS, Versi E. 2005. Validation of the urgency perception scale. BJU International 95:591-596.
4. Cardozo L, Lisec M, Millard R, Vierssen Trip OV, Kuzmin I, Drogendijk TE, et al. 2004. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. Journal of Urology 172:1919-1924.
5. Chapple CR, Artibani W, Cardozo LD, Castro-Diaz D, Craggs M, Haab F, et al. 2005. The role of urinary urgency and its measurement in the OAB symptom syndrome: current concepts and future prospects. BJU International 95:335-340.
6. Chapple CR, Gormley EA. 2006. Development in pharmacological therapy for the OAB. BJU International S1:78-87.
7. Chapple CR, Rechberger T, Al-Shukri, Meffan P, Everaert K, Huang M, et al. 2004. Randomized, double-blind placebo and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU International 93:303-310.
8. Coyne KS, Tubaro A, Brubaker L, Bavendam T. 2006. Development and validation of patient-reported outcomes measures for overactive bladder: a review of concepts. Urology 68:S9-S16. Duggan P. 2005. Incontinence. In: Finn M, Bowyer L, Carr S, O'Connor V, Vollenhoven B, editors. Women's Health. A Core Curriculum. Sydney: Elsevier Mosby. p 229-233.
9. Hashim H, Abrams P. 2007. Overactive bladder: an update. Current Opinion in Urology 17:231-236.
10. Kelleher CJ, Cardozo L, Chapple CR, Haab F, Ridder AM. 2005. Improved quality-of-life in patients with overactive bladder symptoms treated with solifenacin. BJU International 95:81-81.
11. Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J. 2006. Anti-cholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews 4:CD003781.
12. Stewart WF, Herzog AR, Wein AJ, Abrams P, Payne C, Corey R, et al. 2001. Prevalence and impact of overactive bladder in the United States: Results from the NOBLE program. Neurology and Urodynamics 20:403-422.
13. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, et al. 2003. Prevalence and burden of overactive bladder in the United States. World Journal of Urology 20:327-326.
14. Yalcin I, Bump RC. 2003. Validation of two global impression questionnaires for incontinence. American Journal of Obstetrics and Gynecology 189:98-101.